GNS Healthcare

Silver Sponsor

GNS is the leader in the application of Causal AI and simulation technology to discover and validate novel drug targets, simulate clinical trials, and help pharmaceutical and biotech companies discover and develop new medicines faster. GNS’ patented AI uncovers new insights from multi-omics and real-world data leading to the discovery and prioritization of novel biological targets, and more efficient clinical trials with patients who are likely to respond to therapies. The Gemini Digital Twin models across oncology, auto-immune diseases, and neurology enable the simulation of disease progression and drug response at the individual patient level to simulate clinical trials in diverse patient cohorts. GNS’ partners include seven out of the top ten pharmaceutical companies, leading research centers, medical societies, and patient advocacy groups globally. Our advisory board consists of a renowned group of scientific and medical experts.

"Simulating these Digital Twin models allow us to drive improved clinical trial design, and generate real-world evidence to maximize the impact ofdrugs for patients"
The science behind GNS's success is the industry’s most validated and peer reviewed causal AI and simulation
Colin Hill, CEO and Co-founder


Get involved at BioTechX




Alistair Wilmot


Danielle Thomas


Eleanor Lathbridge



Joanna Magaji


Taira Marshall



Diana Cobzac